HOME >> BIOLOGY >> NEWS
Inhibition Of A Novel Gene Involved In Phosphorylating Starch In TransgenicPotato Tubers Leads To The Repression Of Cold Induced Sweetening

Scientists at the Max Planck Institute of Molecular Plant Physiology in Golm, Germany, have isolated a novel gene that is responsible for the phosphorylation of starch. The effects which occur if the expression of this gene is inhibited are described in the May issue of Nature Biotechnology.

Starch is composed of amylose and amylopectin, which are slightly or more highly branched glucose polymers. In addition, amylopectin can, depending on the plant organ where it is manufactured, contain different levels of phosphate monoesters. The phosphate content in potato tubers is exceptionally high as compared with other plant storage organs. Starch biosynthesis is accomplished by different forms of starch synthase which polymerize the glucose monomers using ADP-glucose, and isoforms of branching enzyme which introduce the branch points. Other enzymes are needed to determine the final starch structure, e.g. the presence of a debranching enzyme is a prerequisite to synthesize the semi-crystalline starch granules in contrast to non-crystalline glycogen, which accumulates in eukaryotes other than plants, in bacteria, or in mutants of different plant species lacking this enzyme.

Even though many starch biosynthetic enzymes are known, it has never been possible to synthesize semi-crystalline glucans in vitro, nor has it been explained how the phosphate monoesters are incorporated into starch. Furthermore, it is not clear at the moment which enzymes are responsible for the breakdown of starch in vegetative plant organs. In order to address these open questions in starch metabolism, researchers working in Jens Kossmanns in the department headed by Lothar Willmitzer at the Max Planck Institute of Molecular Plan
'"/>

Contact: Jens Kossmann
Kossmann@Mpimp-Golm.MPG.de
+49-331-9772-784
Max-Planck-Gesellschaft
14-May-1998


Page: 1 2 3 4

Related biology news :

1. Inhibition of cathepsin proteases inhibits tumor formation in transgenic mice
2. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
3. Inhibition of Borrelia burgdorferi protein may reduce Lyme disease transmission
4. Competitive Inhibition May Enhance Safety Of Minimally Processed Fruits And Vegetables
5. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
6. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
7. Novel approaches to current cellular therapies continue progress toward disease prevention
8. Novel therapies show promise against myeloid leukemia
9. Novel sensors help clear the air
10. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
11. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: